Articles

• Antiplatelets, ACE inhibitors, and statins combination reduces stroke severity and tissue at risk

  S. Kumar, S. Savitz, G. Schlaug, L. Caplan, M. Selim

  • Abstract
  • Full Text
  • Full Text (PDF)
• MR diffusion-weighted imaging and outcome prediction after ischemic stroke

  P. J. Hand, J. M. Wardlaw, C. S. Rivers, P. A. Armitage, M. E. Bastin, R. I. Lindley, M. S. Dennis

  • Abstract
  • Full Text
  • Full Text (PDF)
• Statin treatment and adherence to national cholesterol guidelines after ischemic stroke

  B. Ovbiagele, J. L. Saver, H. Bang, L. E. Chambless, A. Nassief, J. Minuk, J. F. Toole, J. R. Crouse

  • Abstract
  • Full Text
  • Full Text (PDF)
• Is IV tissue plasminogen activator beneficial in patients with hyperdense artery sign?

  A. I. Qureshi, M. A. Ezzeddine, A. Nasar, M.F.K. Suri, J. F. Kirmani, N. Janjua, A. A. Divani

  • Abstract
  • Full Text
  • Full Text (PDF)
• Hematoma growth is a determinant of mortality and poor outcome after intracerebral hemorrhage

  S. M. Davis, J. Broderick, M. Hennerici, N. C. Brun, M. N. Diringer, S. A. Mayer, K. Begtrup, T. Steiner

  • Abstract
  • Full Text
  • Full Text (PDF)
• Long-term mortality after intracerebral hemorrhage

  M. L. Flaherty, M. Haverbusch, P. Sekar, B. Kissela, D. Kleindorfer, C. J. Moomaw, L. Sauerbeck, A. Schneider, J. P. Broderick, D. Woo

  • Abstract
  • Full Text
  • Full Text (PDF)
• Prospective study of symptomatic atherothrombotic intracranial stenosesThe GESICA Study

  M. Mazighi, R. Tanasescu, X. Ducrocq, E. Vicaut, S. Bracard, E. Houdart, F. Woimant

  • Abstract
  • Full Text
  • Full Text (PDF)
• Normalizing motor-related brain activitySubthalamic nucleus stimulation in Parkinson disease

  S. T. Grafton, R. S. Turner, M. Desmurget, R. Bakay, M. Delong, J. Vitek, M. Crutcher

  • Abstract
  • Full Text
  • Full Text (PDF)
• Selegiline slows the progression of the symptoms of Parkinson disease

  S. Pålhagen, E. Heinonen, J. Hägglund, T. Kaugesaar, O. Mäki-Ikola, R. Palm, the Swedish Parkinson Study Group

  • Abstract
  • Full Text
  • Full Text (PDF)
• Ataxia with oculomotor apraxia type 2A clinical, pathologic, and genetic study

  C. Criscuolo, L. Chessa, S. Di Giandomenico, P. Mancini, F. Saccà, G. S. Grieco, M. Piane, F. Barbieri, G. De Michele, S. Banfi, F. Pierelli, N. Rizzuto, F. M. Santorelli, L. Gallosti, A. Filla, C. Casali

  • Abstract
  • Full Text
  • Full Text (PDF)
• The effect of noninvasive ventilation on ALS patients and their caregivers

  N. Mustfa, E. Walsh, V. Bryant, R. A. Lyall, J. Addington-Hall, L. H. Goldstein, N. Donaldson, M. I. Polkey, J. Moxham, P. N. Leigh

  • Abstract
  • Full Text
  • Full Text (PDF)
• Identification of potential CSF biomarkers in ALS

  G. M. Pasinetti, L. H. Ungar, D. J. Lange, S. Yemul, H. Deng, X. Yuan, R. H. Brown, M. E. Cudkowicz, K. Newhall, E. Peskind, S. Marcus, L. Ho

  • Abstract
  • Full Text
  • Full Text (PDF)
• Novel congenital myasthenic syndromes associated with defects in quantal release

  M. Milone, T. Fukuda, X. M. Shen, A. Tsujino, J. Brengman, A. G. Engel

  • Abstract
  • Full Text
  • Full Text (PDF)
• A novel locus for hereditary spastic paraplegia with thin corpus callosum and epilepsy

  S. Al-Yahyaee, L. I. Al-Gazali, P. De Jonghe, H. Al-Barwany, M. Al-Kindi, E. De Vriendt, P. Chand, R. Koul, P. C. Jacob, A. Gururaj, L. Sztriha, A. Parrado, C. Van Broeckhoven, R. A. Bayoumi

  • Abstract
  • Full Text
  • Full Text (PDF)
• Does multiple sclerosis–associated disability differ between races?

  R. A. Marrie, G. Cutter, T. Tyry, T. Vollmer, D. Campagnolo

  • Abstract
  • Full Text
  • Full Text (PDF)